![]() |
![]() |
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 156.91 | ACUITE B | Downgraded | Issuer not co-operating* | - |
Total Outstanding | 156.91 | - | - |
Total Withdrawn | 0.00 | - | - |
* The issuer did not co-operate; based on best available information. |
Rating Rationale |
Acuité has downgraded its long term rating to ‘ACUITE B' (read as ACUITE B) from 'ACUITE B+' (read as ACUITE B plus) on the Rs. 156.91 Cr. bank facilities of Medicant Hospital and Research Centre Private Limited (MHRCPL). The rating is now flagged as “Issuer Not-Cooperating” on account of information risk and is based on the best available information. The rating has been downgraded on account of information risk.
|
About the Company |
Medicant Hospital and Research Centre Private Limited (MHRCPL) is a New Delhi based company incorporated on 23rd Nov 2016. The directors are Dr. Majid Ahmed Talikoti, Dr. Jahan Ara Talikoti, Dr. Uma Kishore, Rajesh Kumar, Shiwani, Jagdish Teli. MHRCPL is setting up a 315-bed Super Multi speciality hospital at Bokaro, Jharkhand with total investment of around Rs. 202.95 Cr. The hospital is envisioned to have the latest technology, advanced machines apart from being NABH (National Accreditation Board for Hospitals & Healthcare Providers) and NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited. MHRCPL is scheduled to commence its project in February 2024.
|
Unsupported Rating |
Not Applicable |
Non-cooperation by the issuer/borrower |
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. Acuité believes that information risk is a critical component in such ratings, and noncooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is, therefore, being flagged as “Issuer not-cooperating”, in line with prevailing SEBI regulations and Acuité’s policies.
|
Limitation regarding information availability |
Rating Sensitivities |
No information provided by the issuer / available for Acuite to comment upon.
|
Liquidity Position |
No information provided by the issuer / available for Acuite to comment upon.
|
Outlook: Not Applicable |
|
Other Factors affecting Rating |
None
|
Particulars | Unit | FY 24 (Actual) | FY 23 (Actual) |
Operating Income | Rs. Cr. | 0.03 | 0.00 |
PAT | Rs. Cr. | (1.19) | (0.22) |
PAT Margin | (%) | (4736.47) | 0.00 |
Total Debt/Tangible Net Worth | Times | 2.30 | 0.96 |
PBDIT/Interest | Times | 0.00 | (9.14) |
Status of non-cooperation with previous CRA |
Not Applicable |
Interaction with Audit Committee anytime in the last 12 months (applicable for rated-listed / proposed to be listed debt securities being reviewed by Acuite) |
Not applicable |
Any other information |
None
|
Applicable Criteria |
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Service Sector: https://www.acuite.in/view-rating-criteria-50.htm |
Note on complexity levels of the rated instrument |
|
|
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
* The issuer did not co-operate; based on best available information. |
Contacts |
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |